top of page

About Us
Journal
Platform
Pipeline
Engage
Contact

Canurta Website Images.jpg

Canurta Journal

A collection of news, scientific papers and impact across industry, academia and events.

All Posts
Research
Events
Awards
News
Blog
Newsletter

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Cannabistilbene I as a Potential Therapeutic for Cardiac Hypertrophy: Modulating Key Enzymes and Metabolic Pathways

Oct 11, 2024

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

Oct 10, 2024

CEO Letter: Financing Tailwinds, US Showcase for Canurta Naturals, and New R&D Progress

CEO Letter: Financing Tailwinds, US Showcase for Canurta Naturals, and New R&D Progress

CEO Letter: Financing Tailwinds, US Showcase for Canurta Naturals, and New R&D Progress

Sep 30, 2024

Letter from the CEO, CannMedTM 2024 Highlights, and More

Letter from the CEO, CannMedTM 2024 Highlights, and More

Letter from the CEO, CannMedTM 2024 Highlights, and More

Aug 29, 2024

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

Aug 21, 2024

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

Aug 14, 2024

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Aug 7, 2024

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Jul 31, 2024

Canurta Granted First US Patent and Strengthens Québec Industry Partnerships

Canurta Granted First US Patent and Strengthens Québec Industry Partnerships

Canurta Granted First US Patent and Strengthens Québec Industry Partnerships

Jul 30, 2024

Expanding the Frontier of Botanical Pharmacology: Beyond Cannabinoids

Expanding the Frontier of Botanical Pharmacology: Beyond Cannabinoids

Expanding the Frontier of Botanical Pharmacology: Beyond Cannabinoids

Jul 24, 2024

AI: Transforming the Future of Nutraceuticals

AI: Transforming the Future of Nutraceuticals

AI: Transforming the Future of Nutraceuticals

Jul 17, 2024

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

Jul 8, 2024

Investigation of cannflavins as potential anti-SARS-CoV-2 agents

Investigation of cannflavins as potential anti-SARS-CoV-2 agents

Investigation of cannflavins as potential anti-SARS-CoV-2 agents

Jul 1, 2024

FutureBotanica Success, ALS Advocacy, and Canurta’s Expanding Scientific Presence in June 2024

FutureBotanica Success, ALS Advocacy, and Canurta’s Expanding Scientific Presence in June 2024

FutureBotanica Success, ALS Advocacy, and Canurta’s Expanding Scientific Presence in June 2024

Jun 27, 2024

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

Jun 24, 2024

Cannflavin A Displays Both a Hormetic and Neuroprotective Profile Against Alzheimer's Disease Progression

Jun 17, 2024

Canurta Showcases ALS and Neurodegenerative Research at Global Summits and Expands Scientific Leadership

Canurta Showcases ALS and Neurodegenerative Research at Global Summits and Expands Scientific Leadership

Canurta Showcases ALS and Neurodegenerative Research at Global Summits and Expands Scientific Leadership

May 30, 2024

Preclinical Research with a First-in-Class ALS Therapy Formulation

Preclinical Research with a First-in-Class ALS Therapy Formulation

Preclinical Research with a First-in-Class ALS Therapy Formulation

May 24, 2024

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

May 24, 2024

FutureBotanica, 1871 Cannabis Innovation Lab's Pitch, and Bloom Burton & Co. Healthcare Investor Conference

FutureBotanica, 1871 Cannabis Innovation Lab's Pitch, and Bloom Burton & Co. Healthcare Investor Conference

FutureBotanica, 1871 Cannabis Innovation Lab's Pitch, and Bloom Burton & Co. Healthcare Investor Conference

Apr 29, 2024

Transforming Rare Polyphenols into Botanical Drugs

Stay connected & receive updates on new discoveries, product innovation and more.

Yes, I consent to receiving emails from Canurta Therapeutics about news, updates, and relevant content. I understand I can unsubscribe at any time.

Thank you for subscribing.

© 2025 Canurta, Inc. All rights reserved.

bottom of page